Pain syndromes
Gene: CCT5
A single Morrocan family reported in 2006. The missense in this family (H147R) has been assessed in biochemical assays in E coli and archaea bacteria P furiosus, and shown a reduced chaperonin efficiency. Also, C450Y in related chaperonin CCT4 was identified in a stock of Sprague-Dawley rats with an early onset sensory neuropathy.Created: 25 Feb 2021, 4:55 a.m. | Last Modified: 25 Feb 2021, 4:55 a.m.
Panel Version: 0.6
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Neuropathy, hereditary sensory, with spastic paraplegia MIM#256840
Publications
Gene: cct5 has been classified as Amber List (Moderate Evidence).
Gene: cct5 has been classified as Amber List (Moderate Evidence).
Source Expert Review Red was added to CCT5. Added phenotypes Neuropathy, hereditary sensory, with spastic paraplegia, 256840; HSAN with spastic paraplegia for gene: CCT5 Rating Changed from Green List (high evidence) to Red List (low evidence)
gene: CCT5 was added gene: CCT5 was added to Pain syndromes. Sources: Genomics England PanelApp,Expert Review Green Mode of inheritance for gene: CCT5 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: CCT5 were set to 12874111; 16399879; 25124038; 28623285 Phenotypes for gene: CCT5 were set to Neuropathy, hereditary sensory, with spastic paraplegia, 256840; HSAN with spastic paraplegia